ABT January 2028 Options Begin Trading

The article details options strategies for Abbott Laboratories (ABT) to either acquire shares at a discount or enhance returns on existing holdings. Selling a $125.00 strike put offers an effective purchase price of $113.75 if assigned, or a 3.83% annualized premium return (termed 'YieldBoost') if the option expires worthless, with a 69% probability of that outcome. Alternatively, a covered call at the $140.00 strike could yield 17.51% if ABT shares are called away by January 2028, or a 5.11% annualized premium return ('YieldBoost') if the option expires worthless, with a 43% probability, leveraging implied volatilities of 22-24% against a 22% trailing actual volatility.

Analysis

The provided text outlines two specific, long-term options strategies for Abbott Laboratories (ABT) using January 2028 expirations, framed as methods for either discounted acquisition or yield enhancement. For investors seeking to purchase ABT, selling the $125 strike put contract offers a way to establish a cost basis of $113.75 per share, a notable discount from the current price of $132.71, should the option be assigned. Alternatively, if the option expires worthless, which has a stated probability of 69%, the seller would earn a 3.83% annualized return on the cash collateral. For current shareholders, writing a covered call at the $140 strike provides a potential total return of 17.51% if the stock is called away, but caps any further upside. If this call expires worthless, a scenario with a 43% probability, the investor enhances their yield by an annualized 5.11%. Critically, the implied volatilities of the put (24%) and call (22%) options are closely aligned with the stock's actual trailing twelve-month volatility of 22%, suggesting the options are not priced with an excessive risk premium.

Key Decisions for Investors

• Investors bullish on Abbott Laboratories but seeking a lower entry point than the current market price could consider selling the January 2028 $125 put to either acquire shares at an effective cost of $113.75 or earn a 3.83% annualized yield.
• Existing ABT shareholders could write the January 2028 $140 covered call to generate a 5.11% annualized yield enhancement, but must accept a capped total return of 17.51% and forgo any share appreciation above the $140 strike price.
• Given that the options' implied volatility (22-24%) closely mirrors historical volatility (22%), the premiums offered appear to be a fair reflection of recent risk, not an opportunity driven by unusually high market fear.
• Both strategies involve a multi-year commitment until the January 2028 expiration, so they are only suitable for investors with a long-term thesis on ABT and the willingness to tie up capital or their stock position for that duration.